Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Sage Therapeutics revenue
Sage Therapeutics's revenue is $41.2 million.
What is Sage Therapeutics's revenue?
- Sage Therapeutics's revenue growth from 2018 to 2024 is -54.31%.
- Sage Therapeutics has 637 employees, and the revenue per employee ratio is $64,745.
- Sage Therapeutics's peak quarterly revenue was $1.1B in 2020(q4).
- Sage Therapeutics peak revenue was $1.1B in 2020.
- Sage Therapeutics annual revenue for 2023 was 86.5M, 1,024.84% growth from 2022.
- Sage Therapeutics annual revenue for 2024 was 41.2M, -52.3% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Sage Therapeutics historical revenue
Sage Therapeutics's peak revenue was $1.1B in 2020. The peak quarterly revenue was $1.1B in 2020(q4).
Sage Therapeutics's revenue increased from $90.3m in 2018 to $41.2M currently. That's a -54.31% change in annual revenue.
Sage Therapeutics annual revenue
Sage Therapeutics annual revenue over time
| Fiscal year / year | Sage Therapeutics revenue |
|---|---|
| 2018 | $90.3M |
| 2019 | $6.9M |
| 2020 | $1.1B |
| 2021 | $6.3M |
| 2022 | $7.7M |
| 2023 | $86.5M |
| 2024 | $41.2M |
How accurately did Sage Therapeutics' revenue projections match actual performance?
Sage Therapeutics annual growth
Sage Therapeutics saw the greatest revenue growth in 2020, when revenue increased by 16,123.06%.
Sage Therapeutics had the lowest revenue growth in 2021, when revenue changed by -99.43%.
Sage Therapeutics annual growth rate over time
| Year | Sage Therapeutics growth |
|---|---|
| 2019 | -92%↓ |
| 2020 | 16123%↑ |
| 2021 | -99%↓ |
| 2022 | 22%↑ |
| 2023 | 1025%↑ |
| 2024 | -52%↓ |
Sage Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Sage Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | $90.0M | - | $273,000 |
| 2019 | $465,000 | $873,000 | $3.6M | $2.0M |
| 2020 | $2.3M | $1.1M | $1.6M | $1.1B |
| 2021 | $1.6M | $1.6M | $1.4M | $1.6M |
| 2022 | $1.6M | $1.5M | $1.7M | $2.9M |
| 2023 | $3.3M | $2.5M | $2.7M | $78.0M |
| 2024 | $7.9M | $8.7M | $11.9M | $12.8M |
Sage Therapeutics jobs nearby
Do you work at Sage Therapeutics?
Is Sage Therapeutics transparent about its revenue structure?
Sage Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 637 |
| Date Founded | 2010 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 2 |
| Revenue | $41.2M |
| Net Income | -$532,784,000 |
| Gross Proft | $31.8M (2024) |
| PE Ratio | -19.18 |
| Market Capitalization | $7.7B |
| Total Assets | $1,356,449,000 |
| Ticker | SAGE |
Sage Therapeutics jobs you might like
Sage Therapeutics financing
Sage Therapeutics received early financing of $35.0M on 2011-10-18.
| Series | Round size | Date |
|---|---|---|
| Series A | $35M | 10/2011 |
| Series B | $20M | 10/2013 |
| Series C | $38M | 03/2014 |
| Post Ipo Equity | $138M | 04/2015 |
| Post Ipo Equity | $150M | 01/2016 |
| Post Ipo Equity | $175M | 09/2016 |
| Post Ipo Equity | $345M | 11/2017 |
| Post Ipo Equity | $575M | 02/2018 |
| Post Ipo Equity | $575M | 02/2019 |
| Post Ipo Equity | $650M | 11/2020 |
Sage Therapeutics investors
| Investors | Security type |
|---|---|
| Third Rock Ventures | Series A |
| Third Rock Ventures | Series B |
| ARCH Venture Partners | Series B |
| EcoR1 Capital LLC | Series C |
| ARCH Venture Partners | Series C |
| Third Rock Ventures | Series C |
| OrbiMed Advisors | Series C |
| Foresite Capital | Series C |
| Biogen Inc. | Post Ipo Equity |
Sage Therapeutics competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Rigel Pharmaceuticals | $83,403 | $179.3M | 158 | 9 |
| Global Blood Therapeutics | $92,651 | $194.7M | 457 | - |
| Genocea | $53,221 | - | 59 | - |
| Blueprint Medicines | $84,447 | $508.8M | 495 | 12 |
| bluebird bio | $98,505 | $3.7M | 518 | 2 |
| Karyopharm | $107,666 | $145.2M | 442 | 15 |
| Akebia Therapeutics | $94,635 | $160.2M | 324 | 11 |
| SomaLogic | $80,749 | $97.7M | 235 | - |
| Cidara Therapeutics | $44,982 | $49.6M | 68 | 1 |
| Celsion | $46,787 | $500,000 | 29 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Sage Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Sage Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sage Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sage Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sage Therapeutics. The data presented on this page does not represent the view of Sage Therapeutics and its employees or that of Zippia.
Sage Therapeutics may also be known as or be related to SAGE THERAPEUTICS INC., SAGE Therapeutics Inc, SAGE Therapeutics, Inc., Sage Therapeutics, Sage Therapeutics Inc and Sage Therapeutics, Inc.